372 related articles for article (PubMed ID: 15939423)
1. Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease.
Wang J; Sim AS; Wang XL; Salonikas C; Naidoo D; Wilcken DE
Atherosclerosis; 2006 Feb; 184(2):383-8. PubMed ID: 15939423
[TBL] [Abstract][Full Text] [Related]
2. Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes.
Krzyzanowska K; Mittermayer F; Krugluger W; Schnack C; Hofer M; Wolzt M; Schernthaner G
Atherosclerosis; 2006 Nov; 189(1):236-40. PubMed ID: 16414052
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of asymmetric dimethylarginine and homocysteine in microangiopathy-related cerebral damage.
Notsu Y; Nabika T; Bokura H; Suyama Y; Kobayashi S; Yamaguchi S; Masuda J
Am J Hypertens; 2009 Mar; 22(3):257-62. PubMed ID: 19057516
[TBL] [Abstract][Full Text] [Related]
4. Relations between markers of renal function, coronary risk factors and the occurrence and severity of coronary artery disease.
Wang J; Sim AS; Wang XL; Salonikas C; Moriatis M; Naidoo D; Wilcken DE
Atherosclerosis; 2008 Apr; 197(2):853-9. PubMed ID: 17826782
[TBL] [Abstract][Full Text] [Related]
5. Abnormal asymmetric dimethylarginine/nitric oxide balance in patients with documented coronary artery disease: relation to renal function and homocysteine.
Ilhan N; Seckin D; Ilhan N; Ozbay Y
J Thromb Thrombolysis; 2007 Jun; 23(3):205-11. PubMed ID: 17160550
[TBL] [Abstract][Full Text] [Related]
6. Asymmetric dimethylarginine (ADMA) and hyperhomocysteinemia in patients with acute myocardial infarction.
Korandji C; Zeller M; Guilland JC; Vergely C; Sicard P; Duvillard L; Gambert P; Moreau D; Cottin Y; Rochette L
Clin Biochem; 2007 Jan; 40(1-2):66-72. PubMed ID: 17020756
[TBL] [Abstract][Full Text] [Related]
7. Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA.
Sydow K; Hornig B; Arakawa N; Bode-Böger SM; Tsikas D; Münzel T; Böger RH
Vasc Med; 2004 May; 9(2):93-101. PubMed ID: 15521698
[TBL] [Abstract][Full Text] [Related]
8. Asymmetric dimethylarginine in adults with cystathionine β-synthase deficiency.
Rocha MS; Teerlink T; Janssen MC; Kluijtmans LA; Smulders Y; Jakobs C; Tavares de Almeida I; Rivera I; Castro R; Blom HJ
Atherosclerosis; 2012 Jun; 222(2):509-11. PubMed ID: 22484094
[TBL] [Abstract][Full Text] [Related]
9. [The influence of tobacco smoke on plasma atherogenic compounds levels in active smokers (preliminary report)].
Szołtysek-Bołdys I; Sobczak A; Król D
Przegl Lek; 2006; 63(10):979-84. PubMed ID: 17288198
[TBL] [Abstract][Full Text] [Related]
10. Stent placement in patients with coronary heart disease decreases plasma levels of the endogenous nitric oxide synthase inhibitor ADMA.
Ajtay Z; Scalera F; Cziráki A; Horváth I; Papp L; Sulyok E; Szabo C; Martens-Lobenhoffer J; Awiszus F; Bode-Böger SM
Int J Mol Med; 2009 May; 23(5):651-7. PubMed ID: 19360324
[TBL] [Abstract][Full Text] [Related]
11. Asymmetrical dimethylarginine: a novel risk factor for coronary artery disease.
Lu TM; Ding YA; Charng MJ; Lin SJ
Clin Cardiol; 2003 Oct; 26(10):458-64. PubMed ID: 14579916
[TBL] [Abstract][Full Text] [Related]
12. Relationship between L-arginine/asymmetric dimethylarginine, homocysteine, folic acid, vitamin B levels, and coronary artery ectasia.
Koc F; Ardic I; Erdem S; Kalay N; Ozbek K; Yarlioglues M; Ceyhan K; Celik A; Kadi H; Taner A; Sahin S; Onalan O; Kaya MG
Coron Artery Dis; 2010 Dec; 21(8):445-9. PubMed ID: 20861735
[TBL] [Abstract][Full Text] [Related]
13. Time course of asymmetric dimethylarginine and symmetric dimethylarginine levels after successful renal transplantation.
Claes KJ; Bammens B; Kuypers DR; Meijers B; Naesens M; Sprangers B; Vanrenterghem Y; Lerut E; de Loor H; Evenepoel P
Nephrol Dial Transplant; 2014 Oct; 29(10):1965-72. PubMed ID: 24957811
[TBL] [Abstract][Full Text] [Related]
14. Association of homocysteine and asymmetric dimethylarginine with atherosclerosis and cardiovascular events in maintenance hemodialysis patients.
Kumagai H; Sakurai M; Takita T; Maruyama Y; Uno S; Ikegaya N; Kato A; Hishida A
Am J Kidney Dis; 2006 Nov; 48(5):797-805. PubMed ID: 17059999
[TBL] [Abstract][Full Text] [Related]
15. Asymmetric dimethylarginine is not elevated in exfoliation syndrome but symmetric dimethylarginine is related to exfoliative glaucoma.
Blomster H; Puustjärvi T; Kontkanen M; Valtonen P; Teräsvirta M; Uusitalo H
Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):204-9. PubMed ID: 17024436
[TBL] [Abstract][Full Text] [Related]
16. Relationship between Dietary Approaches to Stop Hypertension score and Alternative Healthy Eating Index score with plasma asymmetrical dimethylarginine levels in patients referring for coronary angiography.
Mokhtari Z; Hosseini S; Miri R; Baghestani AR; Zahedirad M; Rismanchi M; Nasrollahzadeh J
J Hum Nutr Diet; 2015 Aug; 28(4):350-6. PubMed ID: 25786774
[TBL] [Abstract][Full Text] [Related]
17. [The effect of plasma asymmetric dimethylarginine (ADMA) level and L-arginine/ADMA ratio on the development of coronary collaterals].
Selçuk MT; Selçuk H; Temizhan A; Maden O; Ulupinar H; Baysal E; Duru E; Saşmaz A
Turk Kardiyol Dern Ars; 2008 Apr; 36(3):150-5. PubMed ID: 18626206
[TBL] [Abstract][Full Text] [Related]
18. Asymmetric dimethylarginine plasma concentrations and L-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow.
Selcuk MT; Selcuk H; Temizhan A; Maden O; Ulupinar H; Baysal E; Ozeke O; Sasmaz A
Coron Artery Dis; 2007 Nov; 18(7):545-51. PubMed ID: 17925608
[TBL] [Abstract][Full Text] [Related]
19. [Plasma asymmetric dimethylarginine and cystatin C levels in patients with coronary artery disease].
YOU L; ZHAO CX; SHAO JM; ZHANG L; WANG DW
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Sep; 38(9):798-800. PubMed ID: 21092647
[TBL] [Abstract][Full Text] [Related]
20. The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (ADMA) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism.
Ozcan O; Cakir E; Yaman H; Akgul EO; Erturk K; Beyhan Z; Bilgi C; Erbil MK
Clin Endocrinol (Oxf); 2005 Aug; 63(2):203-6. PubMed ID: 16060915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
